Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine

被引:11
作者
Urbain, Jean-Luc [1 ]
Scott, Andrew M. [2 ]
Lee, Sze Ting [3 ]
Buscombe, John [4 ]
Weston, Charlotte [4 ]
Hatazawa, Jun [5 ]
Kinuya, Seigo [6 ]
Singh, Baljinder [7 ]
Haidar, Mohamad [8 ]
Ross, Andrew [9 ]
Lamoureux, Francois [9 ]
Kunikowska, Jolanta [10 ]
Wadsak, Wolfgang [10 ]
Dierckx, Rudi [10 ]
Paez, Diana [11 ]
Giammarile, Francesco [11 ]
Lee, Kyung-Han [12 ]
Hyun, O. Joo [12 ]
Moshe, Modiselle [13 ]
Louw, Lizette [13 ]
More, Stuart [13 ]
Nadel, Helen [1 ]
Lee, Daniel [1 ]
Wahl, Richard [1 ]
机构
[1] Soc Nucl Med & Mol Imaging, Reston, VA 20190 USA
[2] Australian & New Zealand Soc Nucl Med, Vermont South, Vic, Australia
[3] Australasian Assoc Nucl Med Specialists, Balmain, NSW, Australia
[4] British Soc Nanomed, Liverpool, England
[5] Asia Oceania Federat Nucl Med & Biol, Osaka, Japan
[6] Japanese Soc Nucl Med, Tokyo, Japan
[7] Soc Nucl Med, Mumbai, India
[8] Arab Soc Nucl Med, Beirut, Lebanon
[9] Canadian Assoc Nucl Med, Rosemere, PQ, Canada
[10] European Assoc Nucl Med, Vienna, Austria
[11] IAEA, Vienna, Austria
[12] Korean Soc Nucl Med, Seoul, South Korea
[13] South African Soc Nucl Med, Cape Town, South Africa
关键词
D O I
10.2967/jnumed.123.265603
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
[No abstract available]
引用
收藏
页码:986 / 991
页数:6
相关论文
共 50 条
  • [31] Inspired by novel radiopharmaceuticals: Rush hour of nuclear medicine
    Yang Liu
    Ya-nan Ren
    Yan Cui
    Song Liu
    Zhi Yang
    Hua Zhu
    Nan Li
    Chinese Journal of Cancer Research, 2023, 35 (05) : 470 - 482
  • [32] Neutron-activated theranostic radionuclides for nuclear medicine
    Tan, Hun Yee
    Yeong, Chai Hong
    Wong, Yin How
    McKenzie, Molly
    Kasbollah, Azahari
    Shah, Mohamad Nazri Md
    Perkins, Alan Christopher
    NUCLEAR MEDICINE AND BIOLOGY, 2020, 90-91 : 55 - 68
  • [33] Theranostic approach in liver cancer: an emerging paradigm to optimize personalized medicine
    Jokar, Narges
    Moradhaseli, Farzad
    Ahmadzadehfar, Hojjat
    Jafari, Esmail
    Nikeghbalian, Saman
    Rasekhi, Ali Reza
    Assadi, Majid
    CLINICAL AND TRANSLATIONAL IMAGING, 2023, 11 (01) : 51 - 70
  • [34] Theranostic approach in liver cancer: an emerging paradigm to optimize personalized medicine
    Narges Jokar
    Farzad Moradhaseli
    Hojjat Ahmadzadehfar
    Esmail Jafari
    Saman Nikeghbalian
    Ali Reza Rasekhi
    Majid Assadi
    Clinical and Translational Imaging, 2023, 11 : 51 - 70
  • [35] Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine
    Silberstein, EB
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (12) : 2190 - 2192
  • [36] Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
    Gutfilen, Bianca
    Valentini, Gianluca
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [37] Amersham radiopharmaceuticals: a global scientific and industrial legacy for nuclear medicine
    Perkins, Alan C.
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (03) : 191 - 193
  • [38] Nuclear medicine and anatomic pathology in personalized medicine: a challenging alliance
    Urbano, Nicoletta
    Scimeca, Manuel
    Bonanno, Elena
    Schillaci, Orazio
    PERSONALIZED MEDICINE, 2018, 15 (06) : 457 - 459
  • [39] Pharmacovigilance in radiopharmaceuticals: factors causing altered images in nuclear medicine
    Langlet, S.
    Hillaire-Buys, D.
    Couret, I.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 77 - 77
  • [40] Voxel based internal dosimetry of radiopharmaceuticals in diagnostic nuclear medicine
    Petoussi-Henss, N.
    Ocampo Ramos, J.
    Zankl, M.
    Li, W.
    Ruehm, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S356 - S357